BENTLEE RUNDELL: Open Payments
NPI 1538649231 · FORT SMITH, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,066 in 126 payments from 15 companies in 2025. Trend: 2023 $1,964 · 2024 $1,871 · 2025 $2,066
Food & beverage: $1,969Education: $97
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $554 |
| AstraZeneca Pharmaceuticals LP | 14 | $315 |
| Novo Nordisk Inc | 16 | $313 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $217 |
| Amgen Inc. | 13 | $197 |
| PFIZER INC. | 23 | $193 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $55 |
| Otsuka America Pharmaceutical, Inc. | 2 | $51 |
| SANOFI-AVENTIS U.S. LLC | 2 | $34 |
| Lilly USA, LLC | 2 | $32 |
Products named: VRAYLAR, QULIPTA, AIRSUPRA, Kerendia, NURTEC ODT, Ozempic, OTEZLA, UBRELVY.
Industry payments across AR — which companies pay providers there.
